Garetosmab, sold under the brand name Pasatru, is a fully human, IgG4 monoclonal antibody used for the treatment of fibrodysplasia ossificans progressiva. It is an activin signaling inhibitor against activin-A.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.